FI863311A0 - PHARMACEUTICAL COMPOSITION INNEHAOLLANDE ACYLERADE FOSFOLIPIDER. - Google Patents
PHARMACEUTICAL COMPOSITION INNEHAOLLANDE ACYLERADE FOSFOLIPIDER.Info
- Publication number
- FI863311A0 FI863311A0 FI863311A FI863311A FI863311A0 FI 863311 A0 FI863311 A0 FI 863311A0 FI 863311 A FI863311 A FI 863311A FI 863311 A FI863311 A FI 863311A FI 863311 A0 FI863311 A0 FI 863311A0
- Authority
- FI
- Finland
- Prior art keywords
- appropriate
- pharmaceutically acceptable
- fosfolipider
- acylerade
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The compositions consist of a) a phospholipid of the formula <IMAGE> in which m is two or three, R1 and R2 are, independently of one another, alkyl, alkenyl or acyl each with 10 to 20 C atoms, and X is a direct bond, C1-C4-alkylene, C2-C4-alkenylene or C1-C4-alkylene or C2-C4-alkenylene substituted by hydroxyl, or a pharmaceutically acceptable salt thereof, b) a phospholipid of the formula <IMAGE> in which R3 and R4 are the acyl group of a saturated or unsaturated carboxylic acid with 10 to 20 C atoms and 1 to 2 double bonds, c) a compound or a mixture of compounds with pharmacological properties and, where appropriate, d) a lipid from the group comprising phosphatidylcholines, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, cardiolipin and cholesterol and, where appropriate, a pharmaceutically acceptable carrier solution which is buffered to pH 7.0 to 7.8 and, where appropriate, pharmaceutically acceptable auxiliaries. The compositions can be used in the form of liposomes as administration systems, for example for cancer chemotherapy.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76662585A | 1985-08-19 | 1985-08-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI863311A0 true FI863311A0 (en) | 1986-08-15 |
| FI863311A7 FI863311A7 (en) | 1987-02-20 |
Family
ID=25077017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI863311A FI863311A7 (en) | 1985-08-19 | 1986-08-15 | FARMACEUTISKA KOMPOSITIONER INNEHAOLLANDE ACYLERADE PHOSPHOLIPIDER. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0213523B1 (en) |
| JP (1) | JPS6296431A (en) |
| KR (1) | KR870001838A (en) |
| AT (1) | ATE59002T1 (en) |
| AU (1) | AU591162B2 (en) |
| CA (1) | CA1273575A (en) |
| DD (1) | DD248736A5 (en) |
| DE (1) | DE3676133D1 (en) |
| DK (1) | DK165314C (en) |
| ES (1) | ES2001099A6 (en) |
| FI (1) | FI863311A7 (en) |
| GR (1) | GR862144B (en) |
| HU (1) | HU206045B (en) |
| NO (1) | NO171886C (en) |
| NZ (1) | NZ217239A (en) |
| PH (1) | PH26160A (en) |
| PT (1) | PT83204B (en) |
| ZA (1) | ZA866200B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT85537B (en) * | 1986-08-18 | 1990-06-29 | Univ Texas | METHOD FOR PREPARING A PHARMACEUTICAL ADMINISTRATION SYSTEM CONTAINING PEPTIDES PRESENTING CHIMIOTAXIA |
| DK86988A (en) * | 1987-02-25 | 1988-08-26 | Takeda Chemical Industries Ltd | LIPOSOM PREPARATION AND APPLICATION THEREOF |
| WO1991014423A1 (en) * | 1990-03-20 | 1991-10-03 | Otsuka Pharmaceutical Co., Ltd. | Liposome preparation |
| JPH08510748A (en) * | 1993-05-21 | 1996-11-12 | ザ リポソーム カンパニー、インコーポレーテッド | Reduction of physiological side effects induced by liposomes |
| PT785773E (en) * | 1994-10-14 | 2001-05-31 | Liposome Co Inc | LIPOSOMES OF LIPIDIC ETERES AND THEIR THERAPEUTIC UTILIZATION |
| US7306784B2 (en) | 1998-06-20 | 2007-12-11 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US8038984B2 (en) | 1998-06-20 | 2011-10-18 | Washington University | Membrane-permeant peptide complexes for treatment of sepsis |
| US6589503B1 (en) | 1998-06-20 | 2003-07-08 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| WO2006026184A2 (en) | 2004-08-20 | 2006-03-09 | Washington University | Blood brain barrier permeation peptides |
| JP2006248978A (en) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | New liposome preparation |
| WO2019043026A1 (en) | 2017-08-30 | 2019-03-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3218027A1 (en) * | 1982-05-13 | 1983-11-17 | A. Nattermann & Cie GmbH, 5000 Köln | PHOSPHOLIPID SOLUTIONS |
-
1986
- 1986-07-18 PH PH34151A patent/PH26160A/en unknown
- 1986-08-14 PT PT83204A patent/PT83204B/en not_active IP Right Cessation
- 1986-08-15 CA CA000516015A patent/CA1273575A/en not_active Expired - Lifetime
- 1986-08-15 FI FI863311A patent/FI863311A7/en not_active Application Discontinuation
- 1986-08-18 JP JP61191795A patent/JPS6296431A/en active Pending
- 1986-08-18 AU AU61556/86A patent/AU591162B2/en not_active Ceased
- 1986-08-18 HU HU863618A patent/HU206045B/en not_active IP Right Cessation
- 1986-08-18 EP EP86111368A patent/EP0213523B1/en not_active Expired - Lifetime
- 1986-08-18 NO NO863315A patent/NO171886C/en unknown
- 1986-08-18 GR GR862144A patent/GR862144B/en unknown
- 1986-08-18 AT AT86111368T patent/ATE59002T1/en not_active IP Right Cessation
- 1986-08-18 KR KR1019860006783A patent/KR870001838A/en not_active Ceased
- 1986-08-18 ES ES8601163A patent/ES2001099A6/en not_active Expired
- 1986-08-18 ZA ZA866200A patent/ZA866200B/en unknown
- 1986-08-18 NZ NZ217239A patent/NZ217239A/en unknown
- 1986-08-18 DE DE8686111368T patent/DE3676133D1/en not_active Expired - Lifetime
- 1986-08-18 DK DK392786A patent/DK165314C/en not_active IP Right Cessation
- 1986-08-18 DD DD86293707A patent/DD248736A5/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ217239A (en) | 1989-09-27 |
| EP0213523A2 (en) | 1987-03-11 |
| PT83204A (en) | 1986-09-01 |
| DK165314C (en) | 1993-03-29 |
| DD248736A5 (en) | 1987-08-19 |
| FI863311A7 (en) | 1987-02-20 |
| ATE59002T1 (en) | 1990-12-15 |
| EP0213523B1 (en) | 1990-12-12 |
| AU591162B2 (en) | 1989-11-30 |
| NO863315D0 (en) | 1986-08-18 |
| KR870001838A (en) | 1987-03-28 |
| HU206045B (en) | 1992-08-28 |
| PT83204B (en) | 1989-03-30 |
| PH26160A (en) | 1992-03-18 |
| AU6155686A (en) | 1987-02-26 |
| CA1273575A (en) | 1990-09-04 |
| NO171886B (en) | 1993-02-08 |
| ES2001099A6 (en) | 1988-04-16 |
| HUT41634A (en) | 1987-05-28 |
| GR862144B (en) | 1986-12-23 |
| DE3676133D1 (en) | 1991-01-24 |
| NO171886C (en) | 1993-05-19 |
| JPS6296431A (en) | 1987-05-02 |
| EP0213523A3 (en) | 1987-10-14 |
| DK392786A (en) | 1987-02-20 |
| NO863315L (en) | 1987-02-20 |
| DK165314B (en) | 1992-11-09 |
| ZA866200B (en) | 1987-03-25 |
| DK392786D0 (en) | 1986-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1990004918A3 (en) | Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions | |
| KR890011601A (en) | (Cycloalkylamino) methylenebis (phosphonic acid) and pharmaceuticals containing it as active ingredient | |
| FI863311A0 (en) | PHARMACEUTICAL COMPOSITION INNEHAOLLANDE ACYLERADE FOSFOLIPIDER. | |
| ES514240A0 (en) | A PROCEDURE FOR THE PREPARATION OF NEW 2-CARBAMIMIDOIL-1-, CARBADESTIAPEN-2-EN-3-CARBOXYLATED ACID DERIVATIVES. | |
| EP0237051A3 (en) | Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same | |
| NO178923C (en) | Analogous Process for Preparation of Therapeutically Active 24-Homo Vitamin D Derivatives | |
| FI834702A0 (en) | NITROALIFATHIC FOERENING, DERAS FRAMSTAELLNINGSFOERFARANDE OCH ANVAENDNING | |
| IL87254A0 (en) | Stable oxapenem-3-carboxylic acids,their preparation and pharmaceutical compositions containing them | |
| ES8205224A1 (en) | A PROCEDURE FOR THE PREPARATION OF ACIDS 1-CARBADETIAPEN-2-EM-3-CARBOXILES 6-1-AND 2-SUBSTITUTED. | |
| PT84680A (en) | PROCESS FOR THE PREPARATION OF 1,5-BENZOTHIAZEPINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| ES2087421T3 (en) | (1'S) -HYDROXIALKYLLOXAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS AN INHIBITOR OF BETALACTAMASE. | |
| SE8204791D0 (en) | PROCESS FOR PREPARING ALKOXY-VINCAMINIC ACID ESTERS AND ALKOXY-APOVINCAMINIC ACID ESTERS | |
| PT86422A (en) | PROCESS FOR THE PREPARATION OF DIBENZO] BE-OXEPINE-ACETIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| KR900012934A (en) | Pyrido pyrimidine derivatives, pharmaceutical compositions containing them and methods for preparing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed | ||
| FD | Application lapsed |
Owner name: THE BOARD OF REGENTS UNIVERSITY OF TEXAS |